MRCM
DXCM icon

M&R Capital Management’s DexCom DXCM Stock Holding History

M&R Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$79.2K Hold
1,182
– – 0.02% 203
2024
Q2 		$134K Hold
1,182
– – 0.03% 157
2024
Q1 		$164K Hold
1,182
– – 0.04% 144
2023
Q4 		$147K Buy
+1,182
New +$121K 0.04% 166

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

M&R Capital Management's DXCM Position: Q3 2024 in Review

M&R Capital Management held its DexCom (DXCM) position steady in Q3 2024 at 1,182 shares worth $79.2K. The position accounts for 0.02% of the portfolio, ranked #203.

M&R Capital Management first reported a position in DXCM in Q4 2023 and has held it in 4 quarters since. The position peaked at $164K in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • M&R Capital Management held 1,182 shares of DexCom worth $79.2K as of Q3 2024.
  • M&R Capital Management left its DexCom share count unchanged in Q3 2024.
  • DexCom made up 0.02% of M&R Capital Management's portfolio in Q3 2024, its #203 holding.
  • M&R Capital Management first reported a position in DexCom in Q4 2023 and has held it in 4 quarters since.
  • M&R Capital Management's DexCom position peaked at $164K in Q1 2024.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.